Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
51,704,247
-
Share change
-
-1,877,477
-
Total reported value
-
$2,602,686,438
-
Put/Call ratio
-
133%
-
Price per share
-
$50.35
-
Number of holders
-
282
-
Value change
-
-$125,772,976
-
Number of buys
-
122
-
Number of sells
-
170
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2018
As of 30 Sep 2018,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) was held by
282 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,704,247 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, FMR LLC, STATE STREET CORP, Invesco Ltd., DIMENSIONAL FUND ADVISORS LP, Champlain Investment Partners, LLC, Bank of New York Mellon Corp, GLENMEDE TRUST CO NA, and Fiera Capital Corp.
This page lists
282
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.